HCV superinfection and reinfection

Antiviral Therapy

Volumn 17, Issue 7 PARTB, 2012, Pages 1443-1448

  Blackard, Jason T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

DRUG USE; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCIDENCE; INFECTION RISK; NONHUMAN; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REINFECTION; REVIEW; RISK ASSESSMENT; SPECIES DIVERSITY; SUPERINFECTION; VIRAL CLEARANCE; VIRUS STRAIN;

HEPACIVIRUS; HEPATITIS C; HUMANS; RECOMBINATION, GENETIC; RECURRENCE; SUPERINFECTION;

EID: 84872005157     PISSN: 13596535     EISSN: 20402058     Source Type: Journal    
DOI: 10.3851/IMP2460     Document Type: Review

References (79)

1. Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect 2011; 17:107-115.
2. Hnatyszyn HJ. Chronic hepatitis C and genotyping: the clinical significance of determining HCV genotypes. Antivir Ther 2005; 10:1-11. (Pubitemid 40767627)
3. Chayama K, Hayes C. Hepatitis C virus: How genetic variability affects pathobiology of disease. J Gastroenterol Hepatol 2011; 26:83-95.
4. Rubbia-Brandt L, Quadri R, Abid K, et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol 2000; 33:106-115. (Pubitemid 30418941)
5. Adinolfi LE, Gambardella M, Andreana A, Tripodi M, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33:1358-1364. (Pubitemid 32496971)
6. Domingo E, Gomez J. Quasispecies and its impact on viral hepatitis. Virus Res 2007; 127:131-150. (Pubitemid 47058195)
7. Farci P. New insights into the HCV quasispecies and compartmentalization. Semin Liver Dis 2011; 31:356-374.
8. Seeff LB. Natural history of hepatitis C. Am J Med 1999; 107 Suppl 2:10-15. (Pubitemid 30029077)
9. Blackard JT, Sherman K. Hepatitis C virus coinfection and superinfection. J Infect Dis 2007; 195:519-524. (Pubitemid 46214394)
10. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258:135-140.
11. Prince AM, Brotman B, Lee DH, et al. Protection against chronic hepatitis C virus infection after rechallenge with homologous, but not heterologous, genotypes in a chimpanzee model. J Infect Dis 2005; 192:1701-1709. (Pubitemid 41587819)
12. Bassett SE, Guerra B, Brasky K, et al. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 2001; 33:1479-1487. (Pubitemid 32496985)
13. Mehta SH, Cox A, Hoover DR, et al. Protection against persistence of hepatitis C. Lancet 2002; 359:1478-1483. (Pubitemid 34457766)
14. Grebely J, Conway B, Raffa JD, Lai C, Krajden M, Tyndall M. Hepatitis C virus reinfection in injection drug users. Hepatology 2006; 44:1139-1145. (Pubitemid 44748365)
15. Micallef JM, Macdonald V, Jauncey M, et al. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. J Viral Hepat 2007; 14:413-418. (Pubitemid 46744050)
16. Aitken CK, Lewis J, Tracy SL, et al. High incidence of hepatitis C virus reinfection in a cohort of injecting drug users. Hepatology 2008; 48:1746-1752.
17. Osburn WO, Fisher BE, Dowd KA, et al. Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection. Gastroenterology 2010; 138:315-324.
18. Currie SL, Ryan JC, Tracy D, et al. A prospective study to examine persistent HCV reinfection in injection drug users who have previously cleared the virus. Drug Alcohol Depend 2008; 93:148-154. (Pubitemid 350236602)
19. van de Laar TJ, Molenkamp R, van den Berg C, et al. Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam. J Hepatol 2009; 51:667-674.
20. Pham ST, Bull RA, Bennett JM, et al. Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 2010; 52:1564-1572.
21. Page K, Hahn JA, Evans J, et al. Acute hepatitis C virus infection in young adult injection drug users: a prospective study of incident infection, resolution, and reinfection. J Infect Dis 2009; 200:1216-1226.
22. Backmund M, Meyer K, Edlin B. Infrequent reinfection after successful treatment for hepatitis C virus infection in injection drug users. Clin Infect Dis 2004; 39:1540-1543. (Pubitemid 39518222)
23. Grebely J, Pham ST, Matthews GV, et al. Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection. Hepatology 2012; 55:1058-1069.
24. Grebely J, Knight E, Ngai T, et al. Reinfection with hepatitis C virus following sustained virological response in injection drug users. J Gastroenterol Hepatol 2010; 25:1281-1284.
25. Schröter M, Feucht HH, Zollner B, Schafe P, Laufs R. Multiple infections with different HCV genotypes: prevalence and clinical impact. J Clin Virol 2003; 27:200-204. (Pubitemid 37329341)
26. Schijman A, Colina R, Mukomolov S, et al. Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes. Clin Diagn Lab Immunol 2004; 11:433-435. (Pubitemid 38380831)
27. Blatt LM, Mutchnick MG, Tong MJ, et al. Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States. J Viral Hepat 2000; 7:196-202. (Pubitemid 30337615)
28. Viazov S, Widell A, Nordenfelt E. Mixed infection with two types of hepatitis C virus is probably a rare event. Infection 2000; 28:21-25. (Pubitemid 30093203)
29. Toyoda H, Fukuda Y, Hayakawa T, et al. Presence of multiple genotype-specific antibodies in patients with persistent infection with hepatitis C virus (HCV) of a single genotype: evidence for transient or occult superinfection with HCV of different genotypes. Am J Gastroenterol 1999; 94:2230-2236. (Pubitemid 29374559)
30. Qian KP, Natov SN, Pereira BJ, Lau J. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 2000; 7:153-160. (Pubitemid 30177106)
31. Matsubara T, Sumazaki R, Shin K, Nagai Y, Takita H. Genotyping of hepatitis C virus: coinfection by multiple genotypes detected in children with chronic posttransfusion hepatitis C. J Pediatr Gastroenterol Nutr 1996; 22:79-84. (Pubitemid 26013855)
32. Giannini C, Giannelli F, Monti M, et al. Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease. J Lab Clin Med 1999; 134:68-73. (Pubitemid 29332172)
33. Herring BL, Page-Shafer K, Tobler LH, Delwart E. Frequent hepatitis C virus superinfection in injection drug users. J Infect Dis 2004; 190:1396-1403. (Pubitemid 39334852)
34. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 1995; 60:642-647.
35. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassaemic children. Lancet 1994; 343:388-390. (Pubitemid 24049557)
36. Kao JH, Chen PJ, Wang JT, et al. Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis. J Med Virol 1996; 50:303-308. (Pubitemid 26414458)
37. Kao JH, Chen PJ, Lai MY, Chen D. Superinfection of heterologous hepatitis C virus in a patient with chronic type C hepatitis. Gastroenterology 1993; 105:583-587. (Pubitemid 23213548)
38. Laskus T, Wang LJ, Radkowski M, et al. Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol 2001; 75:2059-2066. (Pubitemid 32147545)
39. Accapezzato D, Fravolini F, Casciaro MA, Paroli M. Hepatitis C flare due to superinfection by genotype 4 in an HCV genotype 1b chronic carrier. Eur J Gastroenterol Hepatol 2002; 14:879-881. (Pubitemid 34913588)
40. Laskus T, Wang LJ, Rakela J, et al. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology 1996; 220:171-176. (Pubitemid 26201674)
41. Ramírez S, Pérez-del-Pulgar S, Carrión JA, et al. Hepatitis C virus superinfection of liver grafts: a detailed analysis of early exclusion of non-dominant virus strains. J Gen Virol 2010; 91:1183-1188.
42. Halfon P, Quentin Y, Roquelaure B, et al. Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children. J Hepatol 1999; 30:970-978. (Pubitemid 29278738)
43. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/1b with that of genotype III/2a or I/1a. Hepatology 1994; 20:1131-1136. (Pubitemid 24323556)
44. Dove L, Phung Y, Bzowej N, Kim M, Monto A, Wright T. Viral evolution of hepatitis C in injection drug users. J Viral Hepat 2005; 12:574-583. (Pubitemid 41532488)
45. Lambers FA, Prins M, Thomas X, et al. Alarming incidence of hepatitis C virus re-infection after treatment of sexually acquired acute hepatitis C virus infection in HIV-infected MSM. AIDS 2011; 25:F21-F27.
46. Thomson EC, Fleming VM, Main J, et al. Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 2011; 60:837-845.
47. Morel V, Descamps V, François C, et al. Emergence of a genomic variant of the recombinant 2k/1b strain during a mixed hepatitis C infection: a case report. J Clin Virol 2010; 47:382-386.
48. Morel V, Fournier C, François C, et al. Genetic recombination of the hepatitis C virus: clinical implications. J Viral Hepat 2011; 18:77-83.
49. Colina R, Casane D, Vasquez S, et al. Evidence of intratypic recombination in natural populations of hepatitis C virus. J Gen Virol 2004; 85:31-37. (Pubitemid 38128867)
50. Kalinina O, Norder H, Magnius L. Full-length open reading frame of a recombinant hepatitis C virus strain from St Petersburg: proposed mechanism for its formation. J Gen Virol 2004; 85:1853-1857. (Pubitemid 39023263)
51. Kalinina O, Norder H, Mukomolov S, Magnius L. A natural intergenotypic recombinant of hepatitis C virus identified in St. Petersburg. J Virol 2002; 76:4034-4043. (Pubitemid 34250567)
52. Noppornpanth S, Lien TX, Poovorawan Y, Smits SL, Osterhaus AD, Haagmans B. Identification of a naturally occurring recombinant genotype 2/6 hepatitis C virus. J Virol 2006; 80:7569-7577. (Pubitemid 44092578)
53. Bhattacharya D, Accola MA, Ansari IH, Striker R, Rehrauer W. Naturally occurring genotype 2b/1a hepatitis C virus in the United States. Virol J 2011; 8:458.
54. Cristina J, Colina R. Evidence of structural genomic region recombination in hepatitis C virus. Virol J 2006; 3:53.
55. Gao F, Nainan OV, Khudyakov Y, et al. Recombinant hepatitis C virus in experimentally infected chimpanzees. J Gen Virol 2007; 88:143-147. (Pubitemid 46085124)
56. Kageyama S, Agdamag DM, Alesna ET, et al. A natural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. J Med Virol 2006; 78:1423-1428. (Pubitemid 44533870)
57. Kurbanov F, Tanaka Y, Avazova D, et al. Detection of hepatitis C virus natural recombinant RF1-2k/1b strain among intravenous drug users in Uzbekistan. Hepatol Res 2008; 38:457-464. (Pubitemid 351593946)
58. Kurbanov F, Tanaka Y, Chub E, et al. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1-2k/1b. J Infect Dis 2008; 198:1448-1456.
59. Lee YM, Lin HJ, Chen YJ, et al. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full-length sequences of two new subtype 6w strains and a recombinant form-2b6w. J Med Virol 2010; 82:57-68.
60. Legrand-Abravanel F, Claudinon J, Nicot F, et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. J Virol 2007; 81:4357-4362. (Pubitemid 46586931)
61. Moreau I, Hegarty S, Levis J, et al. Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland. Virol J 2006; 3:95.
62. Moreno P, Alvarez M, López L, et al. Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient. Virol J 2009; 6:203.
63. Ross RS, Verbeeck J, Viazov S, Lemey P, Van Ranst M, Roggendorf M. Evidence for a complex mosaic genome pattern in a full-length hepatitis C virus sequence. Evol Bioinform Online 2008; 4:249-254.
64. Tallo T, Norder H, Tefanova V, et al. Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time. J Med Virol 2007; 79:374-382. (Pubitemid 46355436)
65. Viazov S, Ross SS, Kyuregyan KK, et al. Hepatitis C virus recombinants are rare even among intravenous drug users. J Med Virol 2010; 82:232-238.
66. Yokoyama K, Takahashi M, Nishizawa T, et al. Identification and characterization of a natural intergenotypic (2b/1b) recombinant hepatitis C virus in Japan. Arch Virol 2011; 156:1591-1601.
67. Zhou Y, Wang X, Hong G, et al. Natural intragenotypic and intergenotypic HCV recombinants are rare in southwest China even among patients with multiple exposures. J Clin Virol 2010; 49:272-276.
68. Calado RA, Rocha MR, Parreira R, Piedade J, Venenno T, Esteves A. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal. J Med Virol 2011; 83:608-615.
69. Demetriou VL, van de Vijver DA, Cyprus HCV. Molecular epidemiology of hepatitis C infection in Cyprus: evidence of polyphyletic infection. J Med Virol 2009; 81:238-248.
70. Xia X, Lu L, Tee KK, et al. The unique HCV genotype distribution and the discovery of a novel subtype 6u among IDUs co-infected with HIV-1 in Yunnan, China. J Med Virol 2008; 80:1142-1152. (Pubitemid 351705992)
71. Sentandreu V, Jiménez-Hernández N, Torres-Puente M, et al. Evidence of recombination in intrapatient populations of hepatitis C virus. PLoS ONE 2008; 3:e3239.
72. Moreno MP, Casane D, López L, Cristina J. Evidence of recombination in quasispecies populations of a Hepatitis C virus patient undergoing anti-viral therapy. Virol J 2006; 3:87.
73. Bernardin F, Herring B, Page-Shafer K, Kuiken C, Delwart E. Absence of HCV viral recombination following superinfection. J Viral Hepat 2006; 13:532-537. (Pubitemid 44100404)
74. Tscherne DMEM, von Hahn T, Jones CT, et al. Superinfection exclusion in cells infected with hepatitis C virus. J Virol 2007; 81:3693-3703. (Pubitemid 46586866)
75. Schaller TA, Appel N, Koutsoudakis G, et al. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J Virol 2007; 81:4591-4603. (Pubitemid 46668657)
76. Binder M, Quinkert D, Bochkarova O, et al. Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J Virol 2007; 81:5270-5283. (Pubitemid 46744436)
77. Reiter J, Pérez-Vilaró G, Scheller N, Mina LBDJ, Meyerhans A. Hepatitis C virus RNA recombination in cell culture. J Hepatol 2011; 55:777-783.
78. Scheel TK, Gottwein JM, Carlsen TH, et al. Efficient culture adaptation of hepatitis C virus recombinants with genotype-specific core-NS2 by using previously identified mutations. J Virol 2011; 85:2891-2906.
79. Lange CM, Zeuzem S. IL28B single nucleotide polymorphisms in the treatment of hepatitis C. J Hepatol 2011; 55:692-701.